Cancer-associated mutations are common in normal human esophagus

October 18, 2018

Unexpectedly, a new study finds that cancer-associated genetic mutations are surprisingly common in aged, healthy esophageal epithelium tissue. The results further our understanding of cancer and aging and underscore how little is known about the mutational evolution within normal tissues, a process likely ubiquitous in the tissues of all living things. As people get older, they accumulate mutations in the healthy cells of normal tissues. Generally, these mutations accumulate passively and do not alter cell behavior. However, if a genetic alteration provides a mutant cell with a competitive edge, these cells become persistent mutant clones, which are thought to be the origin of cancer. Human skin, exposed to the powerful mutagenic power of the sun's light, is the most highly mutated normal tissue - nearly 25% of cells in the sun-exposed skin of middle-aged individuals carry cancer driver mutations. Despite its importance, the extent to which cells accumulate somatic mutations throughout life is poorly understood, particularly in tissues not exposed to mutagens like ultraviolet light. To explore the mutational burden of other tissues, Iñigo Martincorena and colleagues performed targeted gene sequencing of normal esophageal epithelium - a tissue-like skin, which lines the esophagus - from nine human donors ranging from 20 to 75 years of age. While the mutation rate was lower in the esophageal tissue than in skin, Martincorena et al. revealed a strong positive selection of cellular clones carrying mutations in 14 cancer-associated genes. According to the results, by middle age, over half of the esophageal epithelium tissue contained mutant clones. What's more, Martincorena et al. observed a high frequency of mutations in the cancer driver gene NOTCH1 in aged normal esophageal epithelium. These mutations were more common in normal cells than in esophageal cancer cells, suggesting that esophageal cancers are more likely to evolve from cells in epithelium without NOTCH1 mutations.

American Association for the Advancement of Science

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to